Southeast Asia Allergy Immunotherapies Market Research Report 2021
- QYR1042626
- 123 Pages
- March 2017
- Pharmaceuticals
ALK
Stallergenes
HAL
Market Segment by Countries, this report splits Southeast Asia into several key Countries, with revenue, market share and growth rate of Allergy Immunotherapy in these regions, from 2011 to 2021 (forecast), like
Indonesia
Philippines
Thailand
Malaysia
Vietnam
Singapore
Split by product types, with revenue, market share and growth rate of each type, can be divided into
Subcutaneous immunotherapy
Sublingual Immunotherapy
Split by applications, this report focuses on sales, market share and growth rate of Allergy Immunotherapy in each application, can be divided into
Allergic Rhinitis
Allergic Asthma
Other
1 Allergy Immunotherapy Overview 1
1.1 Product Overview and Scope of Allergy Immunotherapy 1
1.2 Classification of Allergy Immunotherapy 2
1.3 Applications of Allergy Immunotherapy 4
1.4 Allergy Immunotherapy Market by Countries 7
1.4.1 Indonesia Status and Prospect (2011-2021) 7
1.4.2 Thailand Status and Prospect (2011-2021) 8
1.4.3 Philippines Status and Prospect (2011-2021) 9
1.4.4 Malaysia Status and Prospect (2011-2021) 10
1.4.5 Singapore Status and Prospect (2011-2021) 11
1.4.6 Vietnam Status and Prospect (2011-2021) 12
1.5 Southeast Asia Allergy Immunotherapy Revenue and Growth Rate (2011-2021) 13
2 Southeast Asia Allergy Immunotherapy by Manufacturers, Type and Application 14
2.1 Southeast Asia Allergy Immunotherapy Market Competition by Manufacturers 14
2.2 Southeast Asia Allergy Immunotherapy by Type 16
2.3 Southeast Asia Allergy Immunotherapy by Countries 17
2.4 Southeast Asia Allergy Immunotherapy by Application 19
3 Indonesia Allergy Immunotherapy 20
3.1 Indonesia Allergy Immunotherapy Revenue (2011-2016) 20
3.2 Indonesia Allergy Immunotherapy Revenue and Market Share by Manufacturers 20
3.3 Indonesia Allergy Immunotherapy Revenue and Market Share by Type 21
3.4 Indonesia Allergy Immunotherapy Revenue and Market Share by Applications 22
4 Philippines Allergy Immunotherapy 24
4.1 Philippines Allergy Immunotherapy Revenue (2011-2016) 24
4.2 Philippines Allergy Immunotherapy Revenue and Market Share by Manufacturers 24
4.3 Philippines Allergy Immunotherapy Revenue and Market Share by Type 25
4.4 Philippines Allergy Immunotherapy Revenue and Market Share by Applications 26
5 Thailand Allergy Immunotherapy 28
5.1 Thailand Allergy Immunotherapy Revenue (2011-2016) 28
5.2 Thailand Allergy Immunotherapy Revenue and Market Share by Manufacturers 28
5.3 Thailand Allergy Immunotherapy Revenue and Market Share by Type 29
5.4 Thailand Allergy Immunotherapy Revenue and Market Share by Applications 30
6 Malaysia Allergy Immunotherapy 32
6.1 Malaysia Allergy Immunotherapy Revenue and Value (2011-2016) 32
6.2 Malaysia Allergy Immunotherapy Revenue and Market Share by Manufacturers 32
6.3 Malaysia Allergy Immunotherapy Revenue and Market Share by Type 33
6.4 Malaysia Allergy Immunotherapy Revenue and Market Share by Applications 34
7 Vietnam Allergy Immunotherapy 36
7.1 Vietnam Allergy Immunotherapy Revenue (2011-2016) 36
7.2 Vietnam Allergy Immunotherapy Revenue and Market Share by Manufacturers 36
7.3 Vietnam Allergy Immunotherapy Revenue and Market Share by Type 37
7.4 Vietnam Allergy Immunotherapy Revenue and Market Share by Applications 38
8 Singapore Allergy Immunotherapy 40
8.1 Singapore Allergy Immunotherapy Revenue and Value (2011-2016) 40
8.2 Singapore Allergy Immunotherapy Revenue and Market Share by Manufacturers 40
8.3 Singapore Allergy Immunotherapy Revenue and Market Share by Type 41
8.4 Singapore Allergy Immunotherapy Revenue and Market Share by Applications 42
9 Southeast Asia Allergy Immunotherapy Manufacturers Analysis 44
9.1 ALK 44
9.1.1 Company Profile 44
9.1.2 Product Information 45
9.1.3 ALK Allergy Immunotherapy Revenue, Gross Margin and Market Share 2015 and 2016 46
9.1.4 Main BusinessBusiness Overview 46
9.2 Stallergenes 47
9.2.1 Company Profile 47
9.2.2 Product Information 49
9.2.3 Stallergenes Allergy Immunotherapy Revenue, Gross Margin and Market Share 2015 and 2016 49
9.2.4 Main BusinessBusiness Overview 50
9.3 HAL 51
9.3.1 Company Profile 51
9.3.2 Product Information 53
9.3.3 HAL Allergy Immunotherapy Revenue, Gross Margin and Market Share 2015 and 2016 53
9.3.4 Main BusinessBusiness Overview 54
10 Global Other Allergy Immunotherapy Developers Analysis 57
10.1 Adamis Pharmaceuticals 57
10.1.1 Company Profile 57
10.1.2 Product Information 58
10.2 Aimmune Therapeutics 59
10.2.1 Company Profile 59
10.2.2 Product Information 60
10.3 Anergis 61
10.3.1 Company Profile 61
10.3.2 Product Information 62
10.4 ASIT biotech 63
10.4.1 Company Profile 63
10.4.2 Product Information 64
10.5 Biomay 64
10.5.1 Company Profile 64
10.5.2 Product Information 66
10.6 Circassia 66
10.6.1 Company Profile 66
10.6.2 Product Information 67
10.7 DBV Technologies 69
10.7.1 Company Profile 69
10.7.2 Product Information 70
10.8 Genentech 71
10.8.1 Company Profile 71
10.8.2 Product Information 72
10.9 Verona Pharma 72
10.9.1 Company Profile 72
10.9.2 Product Information 73
10.10 Laboratorios LETI 74
10.10.1 Company Profile 74
10.10.2 Product Information 76
10.11 Mitsubishi Tanabe Pharma 77
10.11.1 Company Profile 77
10.11.2 Production Information 77
10.12 VentiRx Pharmaceuticals 78
10.12.1 Company Profile 78
10.12.2 Production Information 79
10.13 Sementis 80
10.13.1 Company Profile 80
10.13.2 Product Information 81
10.14 Shionogi 82
10.14.1 Company Profile 82
10.14.2 Production Information 84
10.15 Torii 84
10.15.1 Company Profile 84
10.15.2 Production Information 85
10.16 Tunitas Therapeutics 86
10.16.1 Company Profile 86
10.16.2 Production Information 87
11 Allergy Immunotherapy Manufacturing Cost Analysis 88
11.1 Allergy Immunotherapy Key Raw Materials Analysis 88
11.1.1 Key Raw Materials 88
11.1.2 Price of Key Raw Materials 88
11.2 Proportion of Manufacturing Cost Structure 89
11.2.1 Raw Materials 89
11.2.2 Labor Cost 89
11.2.3 Manufacturing Expenses 92
11.3 Manufacturing Process Analysis of Allergy Immunotherapy 93
12 Industrial Chain, Sourcing Strategy and Downstream Buyers 94
12.1 Allergy Immunotherapy Industrial Chain Analysis 94
12.2 Upstream Raw Materials Sourcing 95
12.3 Raw Materials Sources of Allergy Immunotherapy Major Manufacturers in 2015 95
12.4 Downstream Buyers 97
13 Marketing Strategy Analysis, DistributorsTraders 98
13.1 Marketing Channel 98
13.1.3 Marketing Channel Development Trend 99
13.2 Market Positioning 99
13.2.1 Pricing Strategy 99
13.2.2 Brand Strategy 99
13.3 DistributorsTraders List 100
14 Southeast Asia Allergy Immunotherapy Market Forecast (2016-2021) 101
14.1 Indonesia Allergy Immunotherapy Sales Forecast (2016-2021) 101
14.2 Philippines Allergy Immunotherapy Sales Forecast (2016-2021) 102
14.3 Thailand Allergy Immunotherapy Sales Forecast (2016-2021) 103
14.4 Malaysia Allergy Immunotherapy Sales Forecast (2016-2021) 104
14.5 Vietnam Allergy Immunotherapy Sales Forecast (2016-2021) 105
14.6 Singapore Allergy Immunotherapy Sales Forecast (2016-2021) 106
14.8 Southeast Asia Allergy Immunotherapy Revenue Forecast by Type (2016-2021) 106
14.9 Southeast Asia Allergy Immunotherapy Sales Forecast by Application (2016-2021) 107
15 Research Findings and Conclusion 108
16 Appendix 109
Disclosure Section 109
Research Methodology 109
Data Source 110
Disclaimer 111
Author List 112
Figure Picture of Allergy Immunotherapies 1
Table Classification of Allergy Immunotherapy 2
Figure Southeast Asia Revenue Market Share 2015 and 2016 of Allergy Immunotherapy by Types in 2015 2
Figure Product Picture of Subcutaneous Immunotherapy 3
Figure Product Picture of Sublingual Immunotherapy 3
Table Applications of Allergy Immunotherapy 4
Figure Southeast Asia Revenue Market Share 2015 and 2016 of Allergy Immunotherapy by Applications in 2015 5
Figure Allergic Rhinitis Examples 6
Figure Allergic Asthma Examples 6
Figure Indonesia Allergy Immunotherapy Revenue and Growth Rate (2011-2021) 7
Figure Thailand Allergy Immunotherapy Revenue and Growth Rate (2011-2021) 8
Figure Philippines Allergy Immunotherapy Revenue and Growth Rate (2011-2021) 9
Figure Malaysia Allergy Immunotherapy Revenue and Growth Rate (2011-2021) 10
Figure Singapore Allergy Immunotherapy Revenue and Growth Rate (2011-2021) 11
Figure Vietnam Allergy Immunotherapy Revenue and Growth Rate (2011-2021) 12
Figure Southeast Asia Allergy Immunotherapy Revenue and Growth Rate (2011-2021) 13
Table Southeast Asia Allergy Immunotherapy Revenue (M USD) by Manufacturers (2015 and 2016) 14
Table Southeast Asia Allergy Immunotherapy Revenue Share by Manufacturers (2015 and 2016) 14
Table 2015 Southeast Asia Allergy Immunotherapy Revenue Share by Manufacturers 15
Table 2016 Southeast Asia Allergy Immunotherapy Revenue Share by Manufacturers 15
Table Southeast Asia Allergy Immunotherapy Revenue (M USD) and Market Share by Type (2011-2016) 16
Table Southeast Asia Allergy Immunotherapy Revenue Share by Type (2011-2016) 16
Figure Revenue Market Share of Allergy Immunotherapy by Type (2011-2016) 16
Figure Southeast Asia Allergy Immunotherapy Revenue Growth Rate by Type (2011-2016) 17
Table Southeast Asia Allergy Immunotherapy Revenue (M USD) by Countries (2011-2016) 17
Table Southeast Asia Allergy Immunotherapy Revenue Share by Countries (2011-2016) 18
Figure Revenue Market Share of Allergy Immunotherapy by Countries (2011-2016) 18
Table Southeast Asia Allergy Immunotherapy Revenue (M USD) by Application (2011-2016) 19
Table Southeast Asia Allergy Immunotherapy Sales Share by Application (2011-2016) 19
Figure Sales Market Share of Allergy Immunotherapy by Application (2011-2016) 19
Figure Indonesia Allergy Immunotherapy Revenue (M USD) and Growth Rate (2011-2016) 20
Table Indonesia Allergy Immunotherapy Revenue (M USD) by Manufacturers (2015 and 2016) 20
Table Indonesia Allergy Immunotherapy Market Share by Manufacturers (2015 and 2016) 21
Figure Indonesia Allergy Immunotherapy Market Share by Manufacturers in 2015 21
Table Indonesia Allergy Immunotherapy Revenue (M USD) by Type (2011-2016) 21
Table Indonesia Allergy Immunotherapy Market Share by Type (2011-2016) 22
Figure Indonesia Allergy Immunotherapy Market Share by Type in 2015 22
Table Indonesia Allergy Immunotherapy Revenue (M USD) by Applications (2011-2016) 22
Table Indonesia Allergy Immunotherapy Market Share by Applications (2015 and 2016) 23
Figure Indonesia Allergy Immunotherapy Market Share by Applications in 2015 23
Figure Philippines Allergy Immunotherapy Revenue and Growth Rate (2011-2016) 24
Table Philippines Allergy Immunotherapy Revenue (M USD) by Manufacturers (2015 and 2016) 24
Table Philippines Allergy Immunotherapy Market Share by Manufacturers (2015 and 2016) 25
Figure Philippines Allergy Immunotherapy Market Share by Manufacturers in 2015 25
Table Philippines Allergy Immunotherapy Revenue (M USD) by Type (2011-2016) 25
Table Philippines Allergy Immunotherapy Market Share by Type (2011-2016) 26
Figure Philippines Allergy Immunotherapy Market Share by Type in 2015 26
Table Philippines Allergy Immunotherapy Revenue (M USD) by Applications (2011-2016) 26
Table Philippines Allergy Immunotherapy Market Share by Applications (2011-2016) 27
Figure Philippines Allergy Immunotherapy Market Share by Applications in 2015 27
Figure Thailand Allergy Immunotherapy Revenue and Growth Rate (2011-2016) 28
Table Thailand Allergy Immunotherapy Revenue (M USD) by Manufacturers (2015 and 2016) 28
Table Thailand Allergy Immunotherapy Market Share by Manufacturers (2015 and 2016) 29
Figure Thailand Allergy Immunotherapy Market Share by Manufacturers in 2015 29
Table Thailand Allergy Immunotherapy Revenue (M USD) by Type (2011-2016) 29
Table Thailand Allergy Immunotherapy Market Share by Type (2011-2016) 30
Figure Thailand Allergy Immunotherapy Market Share by Type in 2015 30
Table Thailand Allergy Immunotherapy Revenue (M USD) by Applications (2011-2016) 30
Table Thailand Allergy Immunotherapy Market Share by Applications (2011-2016) 31
Figure Thailand Allergy Immunotherapy Market Share by Applications in 2015 31
Figure Malaysia Allergy Immunotherapy Revenue and Growth Rate (2011-2016) 32
Table Malaysia Allergy Immunotherapy Revenue (M USD) by Manufacturers (2015 and 2016) 32
Table Malaysia Allergy Immunotherapy Market Share by Manufacturers (2015 and 2016) 33
Figure Malaysia Allergy Immunotherapy Market Share by Manufacturers in 2015 33
Table Malaysia Allergy Immunotherapy Revenue (M USD) by Type (2011-2016) 33
Table Malaysia Allergy Immunotherapy Market Share by Type (2011-2016) 34
Figure Malaysia Allergy Immunotherapy Market Share by Type in 2015 34
Table Malaysia Allergy Immunotherapy Revenue (M USD) by Applications (2011-2016) 34
Table Malaysia Allergy Immunotherapy Market Share by Applications (2011-2016) 35
Figure Malaysia Allergy Immunotherapy Market Share by Applications in 2015 35
Figure Vietnam Allergy Immunotherapy Revenue and Growth Rate (2011-2016) 36
Table Vietnam Allergy Immunotherapy Revenue (M USD) by Manufacturers (2015 and 2016) 36
Table Vietnam Allergy Immunotherapy Market Share by Manufacturers (2015 and 2016) 37
Figure Vietnam Allergy Immunotherapy Market Share by Manufacturers in 2015 37
Table Vietnam Allergy Immunotherapy Revenue (M USD) by Type (2011-2016) 37
Table Vietnam Allergy Immunotherapy Market Share by Type (2011-2016) 38
Figure Vietnam Allergy Immunotherapy Market Share by Type in 2015 38
Table Vietnam Allergy Immunotherapy Revenue (M USD) by Applications (2011-2016) 38
Table Vietnam Allergy Immunotherapy Market Share by Applications (2011-2016) 39
Figure Vietnam Allergy Immunotherapy Market Share by Applications in 2015 39
Figure Singapore Allergy Immunotherapy Revenue and Growth Rate (2011-2016) 40
Table Singapore Allergy Immunotherapy Sales by Manufacturers (2015 and 2016) 40
Table Singapore Allergy Immunotherapy Market Share by Manufacturers (2015 and 2016) 41
Figure Singapore Allergy Immunotherapy Market Share by Manufacturers in 2015 41
Table Singapore Allergy Immunotherapy Revenue (M USD) by Type (2011-2016) 41
Table Singapore Allergy Immunotherapy Market Share by Type (2011-2016) 42
Figure Singapore Allergy Immunotherapy Market Share by Type in 2015 42
Table Singapore Allergy Immunotherapy Revenue (M USD) by Applications (2011-2016) 42
Table Singapore Allergy Immunotherapy Market Share by Applications (2011-2016) 43
Figure Singapore Allergy Immunotherapy Market Share by Applications in 2015 43
Table ALK Basic Information List 44
Figure Product Information of ALK 45
Table ALK Allergy Immunotherapy Revenue, Gross Margin and Market Share 2015 and 2016 46
Figure ALK Allergy Immunotherapy Revenue Market Share (2015 and 2016) 46
Figure ALK’s pipeline 47
Table Stallergenes Basic Information List 47
Figure Product Information of Stallergenes 49
Table Stallergenes Allergy Immunotherapy Revenue, Gross Margin and Market Share 2015 and 2016 49
Figure Stallergenes Allergy Immunotherapy Revenue Market Share (2015 and 2016) 50
Figure Pipeline of Stallergenes 51
Table HAL Basic Information List 51
Figure Product Information of HAL 53
Table HAL Allergy Immunotherapy Revenue, Gross Margin and Market Share 2015 and 2016 53
Figure HAL Allergy Immunotherapy Revenue Market Share (2015 and 2016) 54
Figure Main Pillars of HAL 55
Figure HAL Pipeline 55
Table Adamis Pharmaceuticals Basic Information List 57
Table Product Information 58
Table Aimmune Therapeutics Basic Information List 59
Table Product Information 60
Table Anergis Basic Information List 61
Table Product Information 62
Table ASIT biotech Basic Information List 63
Table Product Information 64
Table Biomay Basic Information List 64
Table Product Information 66
Table Circassia Basic Information List 66
Table Product Information 67
Table DBV Technologies Basic Information List 69
Table Product Information 70
Table Genentech Basic Information List 71
Table Product Information 72
Table Verona Pharma Basic Information List 72
Table Product Information 73
Table Laboratorios LETI Basic Information List 74
Table Product Information 76
Table Mitsubishi Tanabe Pharma Basic Information List 77
Table Production Information 77
Table VentiRx Basic Information List 78
Table Production Information 79
Table Sementis Basic Information List 80
Table Product Information 81
Table Shionogi Basic Information List 82
Table Production Information 84
Table Torii Basic Information List 84
Table Production Information 85
Table Tunitas Therapeutics Basic Information List 86
Table Production Information 87
Table Key Suppliers of Raw Materials of Raw Material 88
Table Price of Key Raw Materials 88
Figure Manufacturing Cost Structure of Allergy Immunotherapy 89
Figure 2014 APAC Overview of Average Monthly Labor Cost 90
Figure 2014 Americas Overview of Average Monthly Labor Cost 90
Figure 2014 EMEA Overview of Average Monthly Labor Cost 91
Figure 2010-2015 USA Employment Cost Index (ECI) 91
Figure 2010-2014 China Average Wage of Worker and Growth Rate (CNYa) 92
Figure Manufacturing Process Analysis of Allergy Immunotherapy 93
Figure Allergy Immunotherapy Industrial Chain Analysis 94
Table Raw Materials Sources of Allergy Immunotherapy Major Manufacturers in 2015 95
Table Major Buyers of Allergy Immunotherapy 97
Figure Marketing Channels of Allergy Immunotherapy 98
Table DistributorsTraders List 100
Figure Indonesia Allergy Immunotherapy Revenue and Growth Rate Forecast (2016-2021) 101
Figure Philippines Allergy Immunotherapy Revenue and Growth Rate Forecast (2016-2021) 102
Figure Thailand Allergy Immunotherapy Revenue and Growth Rate Forecast (2016-2021) 103
Figure Malaysia Allergy Immunotherapy Revenue and Growth Rate Forecast (2016-2021) 104
Figure Vietnam Allergy Immunotherapy Revenue and Growth Rate Forecast (2016-2021) 105
Figure Singapore Allergy Immunotherapy Revenue and Growth Rate Forecast (2016-2021) 106
Table Southeast Asia Allergy Immunotherapy Revenue (M USD) Forecast by Type (2016-2021) 106
Table Southeast Asia Allergy Immunotherapy Revenue (M USD) Forecast by Application (2016-2021) 107
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
